RosemaryEZunaMD
Pathology • Oklahoma City, OKCytopathology, Anatomic Pathology, Clinical Pathology
Associate Professor, Pathology (Clinical), University of Oklahoma College of Medicine
Are you Dr. Zuna?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1200 Everett Dr
3anp522
Oklahoma City, OK 73104Phone+1 405-271-5507Fax+1 405-271-3064
Summary
- Dr. Rosemary Zuna, MD is a board certified pathologist in Oklahoma City, Oklahoma. She is currently licensed to practice medicine in Oklahoma and Arkansas. She is affiliated with OU Medical Center Edmond, Oklahoma City VA Medical Center, and OU Health.
Education & Training
University of ColoradoResidency, Pathology-Anatomic and Clinical, 1972 - 1977
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1972
Certifications & Licensure
OK State Medical License 1996 - 2025
AR State Medical License 1977 - 1989- American Board of Pathology Anatomic Pathology
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- Interobserver reproducibility of cervical histology interpretation with and without p16 immunohistochemistry.Amy S Tao, Rosemary Zuna, Teresa M Darragh, Niels Grabe, Bernd Lahrmann
American Journal of Clinical Pathology. 2024-08-01 - 12 citationsA rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.Federica Inturrisi, Silvia de Sanjosé, Kanan T Desai, Casey Dagnall, Didem Egemen
International Journal of Cancer. 2024-01-15 - 43 citationsRacial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype.Camryn M Cohen, Nicolas Wentzensen, Philip E Castle, Mark Schiffman, Rosemary Zuna
Journal of Clinical Oncology. 2023-02-10
Press Mentions
- Selective Synthetic Augmentation with HistoGAN for Improved Histopathology Image ClassificationOctober 1st, 2020
Grant Support
- HPV Type And Biological Potential Of Cervical LesionsNational Cancer Institute2005–2006
